IPO Listing: Gem Aromatics Share Price Lists at ₹333.10 on NSE with 2.5% Premium

Gem Aromatics debuted on the stock market with a moderate listing, reflecting investor interest from its heavily subscribed IPO. While the NSE saw a slight premium at opening, the BSE reflected a more cautious stance with a flat start.

Gem Aromatics IPO Listing Overview

Gem Aromatics shares are listed at ₹333.10 on the National Stock Exchange (NSE), marking a 2.5% premium over the issue price of ₹325. However, the Bombay Stock Exchange (BSE) saw a flat listing at ₹325. The initial public offering, which ran from August 19 to August 21, 2024, attracted strong investor participation, with an overall subscription of 30.45 times.

Subscription Details of Gem Aromatics IPO

The retail segment was subscribed 10.49 times, qualified institutional buyers (excluding anchor investors) subscribed 53.76 times, and non-institutional investors subscribed 45.96 times. 

Read More: No More Waiting: Withdraw Up to ₹1 Lakh Instantly with Angel One!

Post-Listing Share Price Movement

After listing, Gem Aromatics shares on the NSE witnessed upward momentum, climbing to a high of ₹344.90 during intraday trade, translating to gains of about 6% from the issue price. 

Company Profile and IPO Goals

Gem Aromatics is engaged in the production of essential oils, fragrance compounds, and value-added derivatives. The firm aims to utilise the IPO proceeds for repaying debt and general corporate purposes. In FY25, Gem Aromatics recorded an 11% rise in revenue and a 7% growth in net profit, aided by its diversified product offering in the speciality chemicals space.

Conclusion

Gem Aromatics' stock opened with a 2.5% premium on NSE and flat on BSE, reflecting cautious optimism from investors. While it was valued below grey market expectations, its strong IPO subscription and positive post-listing price movement indicate underlying investor confidence in the company's prospects.

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in securities are subject to market risks. Read all related documents carefully before investing.